Determination and Prediction of P-Glycoprotein and Multidrug-Resistance-Related Protein Expression in Breast Cancer with Double-Phase Technetium-99m Sestamibi Scintimammography

Publisher： Karger

E-ISSN： 1423-0232|70|6|403-410

ISSN： 0030-2414

Source： Oncology, Vol.70, Iss.6, 2007-02, pp. : 403-410

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Detection and Prediction of Breast Cancer Using Double Phase Tc-99m MIBI Scintimammography in Comparison with MRI

By  

Oncology Research and Treatment, Vol. 32, Iss. 10, 2009-09 ,pp. : 556-560

Karger

Access to resources Recommend Favorite

Breast Cancer: Monitoring Response to Neoadjuvant Chemotherapy Using Tc-99m Sestamibi Scintimammography

By  

Oncology Research and Treatment, Vol. 26, Iss. 1, 2003-03 ,pp. : 27-31

Karger

Access to resources Recommend Favorite

Effects of Rolapitant Administered Intravenously or Orally on the Pharmacokinetics of Digoxin (P‐glycoprotein Substrate) and Sulfasalazine (Breast Cancer Resistance Protein Substrate) in Healthy Volunteers

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 58, Iss. 2, 2018-02 ,pp. : 202-211

John Wiley & Sons Inc

Access to resources Recommend Favorite

P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells

By Navarro Gemma   Sawant Rupa R   Biswas Swati   Essex Sean   Tros de Ilarduya Conchita   Torchilin Vladimir P  

Nanomedicine, Vol. 7, Iss. 1, 2012-01 ,pp. : 65-78

Future Medicine

Access to resources Recommend Favorite

Technetium-99m Sestamibi/Tetrofosmin Myocardial Perfusion Scanning in Cardiac and Noncardiac Sarcoidosis

By  

Cardiology, Vol. 94, Iss. 3, 2001-03 ,pp. : 193-199

Karger

Access to resources Recommend Favorite